We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
2051
Innovex International
INVX
$2.13B
| $32.3K | ﹤0.01% |
+1,743
| New | +$29K |
|
|
ADAM
2052
Adamas Trust
ADAM
$848M
| $32.3K | ﹤0.01% |
4,628
+4,565
| +7,246% | +$31.7K |
|
2053
Recursion Pharmaceuticals
RXRX
$1.68B
| $32.2K | ﹤0.01% |
6,603
+2,983
| +82% | +$15.7K |
|
2054
Janus International
JBI
$769M
| $32.2K | ﹤0.01% |
3,263
+2,439
| +296% | +$23.5K |
|
2055
FS KKR Capital
FSK
$3.09B
| $32.2K | ﹤0.01% |
2,155
+1,067
| +98% | +$20.2K |
|
2056
ANI Pharmaceuticals
ANIP
$1.82B
| $32.2K | ﹤0.01% |
351
+227
| +183% | +$18.5K |
|
2057
Sunrun
RUN
$2.5B
| $32.1K | ﹤0.01% |
+1,856
| New | +$24.8K |
|
|
CHY
2058
Calamos Convertible and High Income Fund
CHY
$1.04B
| $32K | ﹤0.01% |
+2,850
| New | +$31.4K |
|
2059
Fidelity D&D Bancorp
FDBC
$313M
| $31.9K | ﹤0.01% |
728
+457
| +169% | +$20.1K |
|
2060
Apogee Enterprises
APOG
$897M
| $31.7K | ﹤0.01% |
728
+662
| +1,003% | +$28.4K |
|
2061
Oak Valley Bancorp
OVLY
$281M
| $31.5K | ﹤0.01% |
+1,119
| New | +$31.4K |
|
2062
Eagle Materials
EXP
$6.7B
| $31.2K | ﹤0.01% |
134
+48
| +56% | +$10.9K |
|
2063
NCR Atleos
NATL
$3.45B
| $31.2K | ﹤0.01% |
+794
| New | +$27.6K |
|
2064
Prudential
PUK
$34.8B
| $31.2K | ﹤0.01% |
+1,115
| New | +$29.2K |
|
2065
Telefônica Brasil
VIV
$19.5B
| $31.1K | ﹤0.01% |
2,443
-853
| -26% | -$10.2K |
|
2066
First Majestic Silver
AG
$8.68B
| $31.1K | ﹤0.01% |
2,528
+1,028
| +69% | +$9.53K |
|
2067
Black Stone Minerals
BSM
$3.09B
| $31K | ﹤0.01% |
2,358
+55
| +2% | +$692 |
|
2068
Invesco DB Oil Fund
DBO
$356M
| $31K | ﹤0.01% |
+2,304
| New | +$31.4K |
|
2069
Ducommun
DCO
$2.89B
| $31K | ﹤0.01% |
322
+315
| +4,500% | +$28.5K |
|
2070
Yext
YEXT
$574M
| $30.9K | ﹤0.01% |
+3,628
| New | +$30.8K |
|
2071
Garrett Motion
GTX
$5.86B
| $30.9K | ﹤0.01% |
2,268
+2,256
| +18,800% | +$28.6K |
|
|
HUT
2072
Hut 8
HUT
$10.4B
| $30.7K | ﹤0.01% |
+881
| New | +$22.4K |
|
2073
Yelp
YELP
$1.41B
| $30.6K | ﹤0.01% |
981
+715
| +269% | +$23.4K |
|
2074
Amylyx Pharmaceuticals
AMLX
$2.43B
| $30.5K | ﹤0.01% |
+2,244
| New | +$21.1K |
|
2075
RBC Bearings
RBC
$18.1B
| $30.4K | ﹤0.01% |
78
+26
| +50% | +$10.1K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.